Leap therapeutics announces appointment of richard l. schilsky, md to its board of directors

Cambridge, mass. , sept. 6, 2022 /prnewswire/ -- leap therapeutics, inc. (nasdaq: lptx), a biotechnology company focused  on developing targeted and immuno-oncology therapeutics, today announced the appointment of richard l.
LPTX Ratings Summary
LPTX Quant Ranking